|
ZNF618 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.49150003458942E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.0414999995767E-07 |
| Normal-vs-Stage2 |
5.601200E-03 |
| Normal-vs-Stage3 |
8.28140001019051E-09 |
| Normal-vs-Stage4 |
2.84590129240314E-11 |
| Stage1-vs-Stage2 |
1.820640E-01 |
| Stage1-vs-Stage3 |
1.136150E-01 |
| Stage1-vs-Stage4 |
2.009000E-04 |
| Stage2-vs-Stage3 |
2.547600E-02 |
| Stage2-vs-Stage4 |
3.842800E-04 |
| Stage3-vs-Stage4 |
5.186100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.22160001506211E-09 |
| Normal-vs-AfricanAmerican |
4.756000E-02 |
| Normal-vs-Asian |
1.07299999996258E-07 |
| Caucasian-vs-AfricanAmerican |
8.145700E-02 |
| Caucasian-vs-Asian |
6.210000E-01 |
| AfricanAmerican-vs-Asian |
1.062000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.68880000054273E-07 |
| Normal-vs-Female |
1.30190003222452E-09 |
| Male-vs-Female |
8.590800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.65480000205542E-08 |
| Normal-vs-Age(41-60Yrs) |
2.77109999946568E-07 |
| Normal-vs-Age(61-80Yrs) |
2.84159999974776E-07 |
| Normal-vs-Age(81-100Yrs) |
1.824620E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.943200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.091400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.025000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.389200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.672200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.041400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.39610000005064E-06 |
| Classical-VS-Follicular |
1.025040E-01 |
| Classical-VS-Other |
7.136200E-01 |
| Classical-VS-Normal |
4.85069995281862E-09 |
| Tall-VS-Follicular |
1.00979999995143E-06 |
| Tall-VS-Other |
2.355600E-01 |
| Tall-VS-Normal |
2.55218068900831E-12 |
| Follicular-VS-Other |
4.200400E-01 |
| Follicular-VS-Normal |
1.883460E-03 |
| Other-VS-Normal |
1.489930E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.95940000002892E-06 |
| Normal-vs-N1 |
5.08660003006867E-10 |
| N0-vs-N1 |
1.322960E-03 |
|
|
